- Who can participate: Eligible participants are adults aged 18 to 65 years who have been diagnosed with Condition X. Key eligibility criteria include stable health status and no participation in other clinical trials within the last 30 days.
- Study details: Participants will receive either the investigational treatment or a placebo. The study is double-blind, meaning neither the participants nor the researchers will know who receives the actual treatment until the study concludes.

